AR080289A1 - Agente precursor de iodo para la obtencion de imagenes pet de placas amiloides - Google Patents

Agente precursor de iodo para la obtencion de imagenes pet de placas amiloides

Info

Publication number
AR080289A1
AR080289A1 ARP110100377A ARP110100377A AR080289A1 AR 080289 A1 AR080289 A1 AR 080289A1 AR P110100377 A ARP110100377 A AR P110100377A AR P110100377 A ARP110100377 A AR P110100377A AR 080289 A1 AR080289 A1 AR 080289A1
Authority
AR
Argentina
Prior art keywords
pet images
precursor agent
obtaining pet
amyloid
iodo
Prior art date
Application number
ARP110100377A
Other languages
English (en)
Inventor
Heribert Schmitt-Willich
Tobias Heinrich
Damian Brockschnieder
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of AR080289A1 publication Critical patent/AR080289A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP110100377A 2010-02-08 2011-02-04 Agente precursor de iodo para la obtencion de imagenes pet de placas amiloides AR080289A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10075054 2010-02-08

Publications (1)

Publication Number Publication Date
AR080289A1 true AR080289A1 (es) 2012-03-28

Family

ID=43645878

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100377A AR080289A1 (es) 2010-02-08 2011-02-04 Agente precursor de iodo para la obtencion de imagenes pet de placas amiloides

Country Status (4)

Country Link
AR (1) AR080289A1 (es)
TW (1) TW201201846A (es)
UY (1) UY33218A (es)
WO (1) WO2011095593A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用
WO2018089491A1 (en) * 2016-11-08 2018-05-17 The Regents Of The University Of California Methods for multi-dose synthesis of [f-18]fddnp for clinical settings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27003A1 (es) * 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
EP2163541A1 (en) * 2008-09-12 2010-03-17 Bayer Schering Pharma Aktiengesellschaft Piperazine derivatives for binding and imaging amyloid plaques and their use

Also Published As

Publication number Publication date
TW201201846A (en) 2012-01-16
WO2011095593A1 (en) 2011-08-11
UY33218A (es) 2011-09-30

Similar Documents

Publication Publication Date Title
BR112013010441A2 (pt) doença inflamatória
BR112012019789A2 (pt) métodos e aparelhos para sintetizar agentes de imagiologia, e seus intermediários
BR112012019497A2 (pt) aparelho de freio eletromecanico
BR112013009605A2 (pt) sistema de alerta para doença infecciosa
BR112014004908A2 (pt) aparelho para higienizar dispositivo médicos
BR112012028909A2 (pt) cápsulas coacervadas de núcleo sólido
LT2970345T (lt) 18f-žymėti pozitronų emisijos tomografijos (pet) vizualizacijos agentai, nukreipti į prostatos atžvilgiu specifinius membranos antigenus (psma)
BR112012031789A2 (pt) sistema de toalete para cães
GB201020314D0 (en) Apoptosis pet imaging agents
BR112013033913A2 (pt) dispositivo de obtençao de imagem médica
FI20105941A (fi) Kipsausmateriaalit
BRPI1008706A2 (pt) dispositivo para diagnóstico.
ES2433591T8 (es) Dispositivo para la limpieza de espacios interdentales
DK2734834T3 (da) Røntgenbilleddannelse
UY33152A (es) Formulaciones adecuadas para el diagnostico por imagenes con pet
BR112013013929A2 (pt) composição de nanopartícula, e, processos para fabricar uma composição de nanopartícula e de formação de imagem de diagnóstico
CO6920300A2 (es) Agente de dispersión para suspensiones sólidas
DK2609859T3 (da) Røntgenapparat
BRPI1015033A2 (pt) máquina para fundição contínua
AR080289A1 (es) Agente precursor de iodo para la obtencion de imagenes pet de placas amiloides
BR112014005758A2 (pt) aparelho para formação de imagem panorâmica
ES1082604Y (es) Dispositivo para la captacion de infracciones de trafico
ES1071624Y (es) Dispositivo para ventilacion mecanica controlada
ES1071067Y (es) Dispositivo para la grabacion de imagenes del trafico
ES1073400Y (es) Dispositivo potenciador para la natacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure